Niigata, Japan

Yoshihei Hirasawa


Average Co-Inventor Count = 4.5

ph-index = 2

Forward Citations = 34(Granted Patents)


Company Filing History:


Years Active: 1982-1983

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Yoshihei Hirasawa: Innovator in Medical Treatments

Introduction

Yoshihei Hirasawa is a notable inventor based in Niigata, Japan. He has made significant contributions to the field of medical treatments, particularly in the area of cancer and autoimmune diseases. With a total of 3 patents to his name, Hirasawa's work has the potential to impact many lives.

Latest Patents

Hirasawa's latest patents include a method of treating leukemia or leukemoid diseases. This method involves the administration of a vitamin D derivative with a hydroxyl group at the 1.alpha.-position. It is believed that this vitamin D derivative can treat cancer through the redifferentiation of cancer cells. Another significant patent is a method for suppressing abnormal rises in immunological function, which often leads to various autoimmune diseases. This method utilizes cholecalciferol or its derivative to help patients suffering from such conditions.

Career Highlights

Hirasawa is currently associated with Chugai Seiyaku Kabushiki Kaisha, a prominent pharmaceutical company. His work there focuses on developing innovative treatments that address critical health issues. His research has garnered attention for its potential applications in modern medicine.

Collaborations

Hirasawa has collaborated with notable colleagues, including Tadao Aoki and Hideo Miyakoshi. These partnerships have contributed to the advancement of his research and the development of his patents.

Conclusion

Yoshihei Hirasawa's contributions to medical science through his patents highlight his innovative spirit and dedication to improving health outcomes. His work continues to inspire advancements in treatment methodologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…